Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Reportlinker Adds Cell Therapy - Technologies, Markets and Companies

September 7, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 7 /- Reportlinker.com announces that a new market research report is available in its catalogue: Cell Therapy - Technologies, Markets and Companies http://www.reportlinker.com/p0203537/Cell-Therapy---Technologies-Markets-and-Companies.html SummaryThis report describes and...

TOPICS:

Will MHLW Changes in Reimbursement Drive Japanese Physicians to Increase Usage of Chronic Dialysis Catheters?

September 7, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

TORONTO, Sept. 7 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, changes in Japan's Ministry of Health Labour and Welfare (MHLW) reimbursement, which encourage facilities to use higher-priced chronic dialysis catheters, will...

TOPICS:

BCM Human Genome Sequencing Center joins NIH's Pharmacogenomics Research Network

September 7, 2010 10:33 am | by Baylor College of Medicine | News | Comments

The Baylor College of Medicine Human Genome Sequencing Center has received a five-year, $2.3 million grant to join the National Institutes of Health's Pharmacogenomics Research Network , a collaborative project that seeks to advance research on how genes affect people's responses to a...

TOPICS:
Advertisement

Kahn Swick & Foti, LLC and Former Louisiana Attorney General Announce Class Complaint Against Beckman Coulter, Inc. on Behalf of Shareholders Who Purchased Shares of BEC From July ...

September 7, 2010 9:45 am | by The Associated Press | News | Comments

Kahn Swick & Foti, LLC ("KSF") (www.ksfcounsel.com (http://www.ksfcounsel.com) ), a nationally recognized Louisiana-based law firm, and KSF partner Charles C. Foti, Jr., former Attorney General of Louisiana, announce that a class action securities case was filed in the United States...

Medtronic says EU clears new CoreValve system

September 7, 2010 8:45 am | by The Associated Press | News | Comments

Medtronic Inc. said Tuesday that regulators in the European Union have approved the latest version of its CoreValve heart system.The CoreValve delivery system is designed to help surgeons replace a diseased aortic valve without taking out the original valve and without open heart surgery....

James F. Szigethy Named Curemark's Director of New Product Development

September 7, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

RYE, N.Y., Sept. 7 /- Curemark ( www.curemark.com ), a drug research and development company focused on the treatment of neurological diseases, announced that James F. Szigethy, formerly a consultant for Curemark, has assumed the position of Director of New Product Development.  In...

TOPICS:

Varian Medical Systems Develops New X-Ray Tube for Use in Security Scanning Systems

September 7, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Sept. 7 /- Varian Medical Systems, Inc. (NYSE: VAR ), has developed a new X-ray tube designed to operate in security systems capable of generating high resolution detailed images needed to detect threats in airports, military bases, prisons, and other secured facilities....

TOPICS:

Study finds more Americans bypassing their personal physician when immediate treatment required

September 7, 2010 8:34 am | by EurekAlert | News | Comments

(Emory University) Only 45 percent of the 354 million annual visits for acute care in the United States are made to patients' personal physicians, as Americans increasingly make busy emergency departments, specialists or outpatient care departments their first point of contact for...

TOPICS:
Advertisement

Experts recommend universal screening of newborns for congenital adrenal hyperplasia

September 7, 2010 8:33 am | by EurekAlert | News | Comments

(The Endocrine Society) Today, the Endocrine Society released a new clinical practice guideline on the diagnosis and treatment of congenital adrenal hyperplasia. The guideline features a series of evidence-based clinical recommendations developed by an expert task force.

TOPICS:

NetMotion Wireless Tapped by IDEXX Laboratories to Provide Secure Mobile Access to Field Personnel

September 7, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Sept. 7 /- NetMotion Wireless, a leading provider of mobile productivity and management software, announced today that its award winning mobile Virtual Private Network (VPN) solution, Mobility XE, has been deployed by IDEXX to improve the performance of hundreds of mobile workers...

TOPICS:

MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences

September 7, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Sept. 7 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that the Company will participate in the following healthcare conferences in September: Morgan Stanley Global Healthcare Conference Tuesday, September 14, at 11:30 a.m. ET in New York Stifel...

TOPICS:

Federal Register: Determination of Regulatory Review Period for Purposes of Patent Extension; BRYAN CERVICAL DISC SYSTEM

September 7, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA has determined the regulatory review period for BRYAN CERVICAL DISC SYSTEM and is publishing this notice of that determination as required by law.

TOPICS:

Beckman Coulter CEO Garrett resigns

September 7, 2010 5:45 am | by The Associated Press | News | Comments

Beckman Coulter Inc., which makes medical testing instruments, said Tuesday that Scott Garrett has resigned as chairman, CEO and president.The board of directors appointed J. Robert Hurley as interim president and CEO. Hurley has served as the company's senior vice president of human resources...

Beckman Coulter CEO Scott Garrett resigns

September 7, 2010 4:45 am | by The Associated Press | News | Comments

Beckman Coulter Inc., which makes medical testing instruments, said Tuesday that Chairman, President and CEO Scott Garrett has resigned.Garrett will remain as a full-time, non-executive employee of the company through Jan. 15.The board of directors appointed J. Robert Hurley as interim...

Marina Biotech, Inc. to Present at the Rodman & Renshaw 12th Annual Healthcare Conference

September 7, 2010 4:45 am | by The Associated Press | News | Comments

Marina Biotech, Inc. (NASDAQ: MRNA), formerly known as MDRNA, Inc., a leading RNAi-based drug discovery and development company, announced today that it will present at the Rodman & Renshaw 12th Annual Healthcare Conference on Monday, September 13, 2010, at 3:15 p.m. Eastern Time (12:15...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading